SVNTE

Savient (SVNTE)

Savient Pharmaceuticals (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SVNTE

日付	受信時刻	ニュースソース	見出し	コード	企業名
2006/01/27	06 : 23	Business Wire	Savient Pharmaceuticals Files Form 10-Q For Period Ended September 30, 2005; Meets Final Filing Deadline for All Late Reports Re	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2006/01/24	05 : 45	Business Wire	Savient Pharmaceuticals Receives Additional Extension from NASDAQ	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2006/01/20	07 : 19	Business Wire	Savient Completes Restatement of 2004 and Prior Period Results; Amended and Initial Quarterly Reports for 2005 Expected to be Fi	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2006/01/10	08 : 30	Business Wire	Savient Pharmaceuticals Closes Sale of Delatestryl(R) Product to Indevus Pharmaceuticals	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2006/01/04	08 : 30	Business Wire	Savient Pharmaceuticals Receives Two-Week Extension from NASDAQ Regarding Late Filings	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/12/02	16 : 30	PR Newswire (US)	Barr, Organon and Savient Finalize Mircette(R) Settlement and Acquisition	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/19	07 : 15	Business Wire	Savient Receives Expected Nasdaq Notice Regarding Delay in Filing Third Quarter Form 10-Q	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/14	22 : 01	PR Newswire (US)	Savient's Puricase(R) (PEG-uricase) Substantially Reduces and Sustains Lower Plasma Urate Levels in Patients with Treatment-Resi	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/07	21 : 41	Business Wire	Savient Pharmaceuticals Provides Business Update; Financial Overview and Recent Strategic Developments	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/02	20 : 30	Business Wire	Savient Pharmaceuticals to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/02	08 : 30	Business Wire	Savient Pharmaceuticals to Provide Business Update on November 7, 2005	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/01	06 : 41	Business Wire	CORRECTING and REPLACING Savient Pharmaceuticals Receives FDA Approval to Market Soltamox(TM); The First Oral Liquid Tamoxifen i	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/11/01	04 : 00	Business Wire	Savient Pharmaceuticals Receives FDA Approval to Market Soltamox(R); The First Oral Liquid Tamoxifen in U.S.; U.K.-based Liquids	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/29	04 : 18	Business Wire	Savient Pharmaceuticals Receives Filing Extension from Nasdaq	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/27	06 : 59	Business Wire	Savient Pharmaceuticals Determines Periods Affected for Restatement Include Six Months Ended June 30, 2005 and Fiscal Years Ende	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/22	07 : 30	Business Wire	Savient Pharmaceuticals, Inc. Announces Second Amended Complaint in Purported Class Action Lawsuit	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/14	20 : 00	Business Wire	Savient Pharmaceuticals, Inc. to Present at the Upcoming BIO Investor Forum 2005	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/14	19 : 30	Business Wire	Savient Audit Committee Completes Review	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/06	07 : 30	Business Wire	Savient Pharmaceuticals Announces CFO Management Change	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/04	07 : 30	Business Wire	Savient Updates NASDAQ Hearing and Restatement Status	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/10/03	19 : 30	Business Wire	Two Abstracts Highlighting Savient Pharmaceuticals' Puricase(R) Accepted for American College of Rheumatology Annual Scientific	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/09/21	20 : 10	Business Wire	Savient Pharmaceuticals Files Citizens' Petition with the FDA for Oxandrin(R); Requests FDA to Not Approve Any ANDA Prior to Exp	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/09/08	21 : 30	PR Newswire (US)	Barr, Organon and Savient Announce Letter of Intent Regarding Mircette(R)	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)
2005/08/19	19 : 30	Business Wire	Savient Receives Nasdaq Delisting Notice Related to Late Form 10-Q	NASDAQ:SVNTE	Savient Pharmaceuticals (MM)